Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
23.24
-1.21 (-4.95%)
At close: Oct 2, 2026, 4:00 PM EDT
23.00
-0.24 (-1.02%)
After-hours: Oct 2, 2026, 7:44 PM EDT
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $3.92 billion as of October 2, 2026. Its market cap has increased by 341.62% in one year.
Market Cap
3.92B
Enterprise Value
2.94B
1-Year Change
341.62%
Ranking
Category
Stock Price
$23.24
ChartMarket Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $3.92B, an increase of 2,406.94%. That is a compound annual growth rate of 80.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 3.92B | 228.39% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 4.45B |
| Relay Therapeutics | 4.15B |
| Parabilis Medicines | 3.74B |
| Xenon Pharmaceuticals | 3.68B |
| IDEAYA Biosciences | 3.60B |
| Legend Biotech | 3.60B |
| Telix Pharmaceuticals | 3.58B |
| Celcuity | 3.53B |